McFarland, James M.
Ho, Zandra V. http://orcid.org/0000-0003-4046-0266
Kugener, Guillaume
Dempster, Joshua M.
Montgomery, Phillip G.
Bryan, Jordan G.
Krill-Burger, John M. http://orcid.org/0000-0001-9614-4671
Green, Thomas M.
Vazquez, Francisca
Boehm, Jesse S. http://orcid.org/0000-0002-6795-6336
Golub, Todd R. http://orcid.org/0000-0003-0113-2403
Hahn, William C. http://orcid.org/0000-0003-2840-9791
Root, David E.
Tsherniak, Aviad http://orcid.org/0000-0002-3797-1877
Funding for this research was provided by:
Carlos Slim Foundation
Article History
Received: 24 April 2018
Accepted: 1 October 2018
First Online: 2 November 2018
Competing interests
: W.C.H. is a consultant for Thermo-Fisher, Paraxel, AjuIB, MPM Capital and KSQ Therapeutics and receives research funding from Deerfield Management. W.C.H. is a founder and has equity in KSQ Therapeutics. T.R.G. is a consultant to Foundation Medicine and GlaxoSmithKline, and is a shareholder of FORMA Therapeutics. D.E.R. receives research funding from members of the Functional Genomics Consortium (Abbvie, Jannsen, Merck, Vir), and is a director of Addgene, Inc. A.T. is a consultant for Tango Therapeutics. All remaining authors declare no competing interests.